Qingyi Zhu Selected Research

Qingyi Zhu Research Topics

Disease

12	Neoplasms (Cancer) 01/2023 - 08/2015
11	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 11/2004
6	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024 - 10/2010
4	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2015
4	Carcinoma (Carcinomatosis) 01/2023 - 06/2002
3	Atherosclerosis 07/2022 - 08/2021
2	Aortic Dissection 12/2023 - 05/2015
2	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2023 - 10/2022
1	Weight Gain 02/2023
1	Carcinogenesis 01/2023
1	Prediabetic State (Prediabetes) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2022
1	Chronic Limb-Threatening Ischemia 05/2022
1	Insulin Resistance 05/2022
1	Body Weight (Weight, Body) 05/2022
1	Diabetes Mellitus 05/2022
1	Ischemia 05/2022
1	Proteinuria 01/2022
1	Inflammation (Inflammations) 01/2022
1	Pre-Eclampsia (Preeclampsia) 01/2022
1	Atherosclerotic Plaque (Atheroma) 08/2021
1	Hyperlipidemias (Hyperlipidemia) 08/2021
1	Convalescence 01/2021
1	Postoperative Pain 01/2021
1	Amyloidosis 01/2021
1	Intestinal Diseases (Diseases, Intestinal) 01/2020
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 09/2018
1	Myelolipoma 09/2018
1	Urinary Calculi (Urinary Calculus) 12/2017
1	Cystinuria 12/2017
1	Fibrosarcoma 08/2015
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 08/2015
1	Glioblastoma (Glioblastoma Multiforme) 08/2015
1	Thalassemia 03/2011
1	beta-Thalassemia (Cooley's Anemia) 03/2011

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 02/2023 - 05/2015
4	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2017
3	MicroRNAs (MicroRNA)IBA 03/2024 - 08/2015
3	oxidized low density lipoproteinIBA 02/2023 - 08/2021
3	CytokinesIBA 07/2022 - 06/2002
2	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 03/2011
2	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 01/2023
2	erucylphosphocholineIBA 07/2022 - 08/2021
2	Acetylcysteine (Siran)FDA LinkGeneric 05/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 08/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	enzalutamideIBA 01/2020 - 01/2017
1	Silicon Dioxide (Silica)FDA LinkGeneric 03/2024
1	S-Adenosylmethionine (Ademetionine)IBA 12/2023
1	Angiotensin IIIBA 12/2023
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2023
1	HDL LipoproteinsIBA 02/2023
1	anillinIBA 01/2023
1	MetalsIBA 01/2023
1	F-actin-binding proteinsIBA 01/2023
1	16S Ribosomal RNAIBA 10/2022
1	Particulate MatterIBA 07/2022
1	Oxygen (Dioxygen)IBA 07/2022
1	Cysteine (L-Cysteine)FDA Link 07/2022
1	Blood Glucose (Blood Sugar)IBA 05/2022
1	Insulin (Novolin)FDA Link 05/2022
1	Advanced Glycation End ProductsIBA 05/2022
1	Catalytic DNA (Deoxyribozyme)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	CreatinineIBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2022
1	LipidsIBA 08/2021
1	CA-125 Antigen (CA 125 Antigen)IBA 01/2021
1	CarbohydratesIBA 01/2021
1	AntigensIBA 01/2021
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 01/2020
1	PhloretinIBA 01/2020
1	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2018
1	SteroidsIBA 09/2018
1	Therapeutic UsesIBA 06/2018
1	isorhapontigeninIBA 02/2018
1	Cystine (L-Cystine)IBA 12/2017
1	Calcium OxalateIBA 12/2017
1	CXC ChemokinesIBA 08/2017
1	Transcription Factors (Transcription Factor)IBA 08/2017
1	AndrogensIBA 08/2017
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	Messenger RNA (mRNA)IBA 08/2015
1	3' Untranslated Regions (3' UTR)IBA 08/2015
1	Peptide Hydrolases (Proteases)FDA Link 08/2015
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 08/2015
1	hemoglobin Q ThailandIBA 03/2011
1	Cyclin D1IBA 10/2010

Therapy/Procedure

4	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2024 - 01/2018
3	Therapeutics 05/2022 - 01/2020
2	Cystectomy 10/2023 - 01/2021
2	Immunotherapy 01/2023 - 01/2023
2	Castration 01/2020 - 01/2017
1	Quantum Dots (Quantum Dot) 03/2024
1	Drug Therapy (Chemotherapy) 01/2023
1	Length of Stay 01/2021
1	Urinary Diversion (Ileal Conduit) 01/2021
1	Nephroureterectomy 03/2020
1	Operative Surgical Procedures 01/2020
1	Minimally Invasive Surgical Procedures 01/2020